Benchmark Cuts Integer (NYSE:ITGR) Price Target to $140.00

Integer (NYSE:ITGR - Free Report) had its price objective reduced by Benchmark from $150.00 to $140.00 in a research report report published on Friday,Benzinga reports. They currently have a buy rating on the medical equipment provider's stock.

Several other equities analysts also recently commented on ITGR. KeyCorp cut their price objective on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Truist Financial dropped their target price on Integer from $163.00 to $140.00 and set a "buy" rating on the stock in a research report on Friday, April 11th. Oppenheimer lowered shares of Integer from an "outperform" rating to a "market perform" rating in a research note on Friday, February 21st. Finally, Raymond James assumed coverage on Integer in a report on Friday, March 28th. They issued an "outperform" rating and a $145.00 price target for the company. One analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, Integer currently has a consensus rating of "Moderate Buy" and a consensus price target of $145.56.

Integer Stock Performance

Shares of ITGR stock traded down $0.58 during mid-day trading on Friday, reaching $122.83. 534,414 shares of the company's stock traded hands, compared to its average volume of 346,168. The company has a debt-to-equity ratio of 0.62, a quick ratio of 2.09 and a current ratio of 2.95. The firm has a 50 day moving average price of $119.58 and a two-hundred day moving average price of $130.28. The firm has a market capitalization of $4.29 billion, a PE ratio of 36.56, a price-to-earnings-growth ratio of 1.72 and a beta of 1.09. Integer has a 12 month low of $104.93 and a 12 month high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last issued its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.04. The company had revenue of $437.39 million for the quarter, compared to the consensus estimate of $428.51 million. Integer had a return on equity of 11.65% and a net margin of 6.92%. The firm's quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter last year, the company earned $1.14 EPS. On average, research analysts forecast that Integer will post 6.01 EPS for the current year.

Hedge Funds Weigh In On Integer

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Lord Abbett & CO. LLC lifted its stake in Integer by 3.5% in the third quarter. Lord Abbett & CO. LLC now owns 290,120 shares of the medical equipment provider's stock valued at $37,716,000 after buying an additional 9,754 shares during the last quarter. Versant Capital Management Inc grew its position in Integer by 98.4% during the fourth quarter. Versant Capital Management Inc now owns 369 shares of the medical equipment provider's stock worth $49,000 after buying an additional 183 shares during the period. GAMMA Investing LLC increased its stake in Integer by 36.0% in the 4th quarter. GAMMA Investing LLC now owns 888 shares of the medical equipment provider's stock valued at $118,000 after purchasing an additional 235 shares in the last quarter. Park Avenue Securities LLC raised its stake in shares of Integer by 26.0% during the 4th quarter. Park Avenue Securities LLC now owns 4,710 shares of the medical equipment provider's stock worth $624,000 after buying an additional 972 shares during the last quarter. Finally, Contravisory Investment Management Inc. raised its position in Integer by 210.8% during the fourth quarter. Contravisory Investment Management Inc. now owns 693 shares of the medical equipment provider's stock worth $92,000 after acquiring an additional 470 shares during the last quarter. 99.29% of the stock is owned by institutional investors and hedge funds.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.